vTv Therapeutics (VTVT) Current Deferred Tax Assets (2021)

vTv Therapeutics' (VTVT) quarterly Current Deferred Tax Assets came in at $135000.0 in Q4 2021.

vTv Therapeutics (VTVT) Current Deferred Tax Assets (2021) Analysis & Trends

vTv Therapeutics has disclosed Current Deferred Tax Assets across 1 years of filings, most recently posting $135000.0 for Q4 2021.

Current Deferred Tax Assets for Q4 2021 came in at $135000.0, changed N/A year-over-year; the trailing twelve-month figure through Dec 2021 was $135000.0 (changed N/A YoY), and the FY2021 annual result was $135000.0, changed N/A from the prior year.
Current Deferred Tax Assets came in at $135000.0 for Q4 2021 at vTv Therapeutics.
In the past five years, Current Deferred Tax Assets ranged from a high of $135000.0 in Q4 2021 to a low of $135000.0 in Q4 2021.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Alterity Therapeutics	925,601.88 Bn	925,601.85 Bn	-
2	Belite Bio	58,560.00 Bn	58,560.00 Bn	-
3	Quantum Biopharma	17,284.41 Bn	17,284.40 Bn	-
4	Legend Biotech	2,809.00 Bn	2,808.71 Bn	242.10 Mn
5	Evaxion A	1,334.43 Bn	1,334.42 Bn	-
6	Akari Therapeutics	1,312.27 Bn	1,312.26 Bn	-
7	Psyence Biomedical	212.16 Bn	212.16 Bn	-
8	Vertex Pharmaceuticals	114.83 Bn	107.58 Bn	2.59 Bn
9	Abivax	91.96 Bn	91.96 Bn	-
10	vTv Therapeutics	426.76 Mn	426.76 Mn	-

Download Data

Date	Value
Dec 31, 2021	135,000.00
Dec 31, 2021	135,000.00